Medical/Pharmaceuticals
AffaMed Therapeutics Announces New Drug Approval for DEXTENZA in Macau for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery
SHANGHAI, April 12, 2022 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products, today announced that DEXTENZA has been approved inMacau, China for...
2022-04-13 10:46
2851
CStone Announces Presentation of Preclinical data on a Multi-Specific Antibody-based Therapeutic Candidate CS2006/NM21-1480 at the American Association for Cancer Research (AACR) Annual Meeting 2022
* Results from pharmacokinetic/pharmacodynamic modeling demonstrated that binding affinity optimization of CS2006/NM21-1480 allowed optimal PD-L1 blockade and 4-1BB stimulation concomitantly, at a broad dose range thereby and facilitating dose-finding in the clinic * CS2006/NM21-1480 was effi...
2022-04-13 08:02
3508
HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies to Expand Growth Initiative
* HanAll Biopharma and Daewoong Pharmaceutical invest in the broad potential of Turn Biotechnologies * Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases SEOUL, South Korea ,April 12, 2022 /PRNewswire/ -- HanAll...
2022-04-13 08:00
2466
JUNIPER BIOLOGICS ACQUIRES CELL-MEDIATED GENE THERAPY TG-C LD FOR TREATMENT OF KNEE OSTEOARTHRITIS
$600 million USD acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients inAsia Pacific, Middle East and Africa SINGAPORE, April 13, 2022 /PRNewswire/ -- Juniper Biologics, a science-led healthcare company focused on researc...
2022-04-13 07:57
2528
Adge Pharmaceuticals advances its rare disease programs, attends ASCEND 2022 Rett Syndrome National Summit.
MOUNTAIN VIEW, Calif., April 13, 2022 /PRNewswire/ -- Adge Pharmaceuticals ("Adge") continues to advance its rare disease programs in the Rett Syndrome and Osteogenesis imperfecta in support of the regulatory requirements of the US FDA to move its lead asset expeditiously to the clinic. In prepa...
2022-04-13 07:00
1703
Cambrex Completes Large-Scale US API Expansion
EAST RUTHERFORD, N.J., April 13, 2022 /PRNewswire/ -- Cambrex announced today the completion of a$50 million expansion of its large-scale active pharmaceutical ingredient (API) manufacturing capabilities at itsCharles City, Iowa facility. The startup of the new manufacturing space is the culminat...
2022-04-13 06:50
1958
Bridge Biotherapeutics Presented the Preclinical Data of BBT-207 at the AACR Annual Meeting 2022
* The preclinical data supports the clinical development of BBT-207 for EGFR mutant NSCLC patients harboring C797S double mutations, as well as for those who are treatment-naïve * The company plans to submit an IND application to the US FDA in 2022 and looks forward to entering the Phase 1 st...
2022-04-13 06:00
1830
MediLink Therapeutics Receives FDA Clearance of IND Application for YL201 Antibody Drug Conjugate Product
SUZHOU, China, April 12, 2022 /PRNewswire/ -- MediLink Therapeutics announced that YL201, the first compound based on MediLink's proprietary antibody-drug conjugate (ADC) technology platform, has been cleared on its Investigational New Drug (IND) application by the U.S. Food and Drug Administrati...
2022-04-12 20:55
1431
Gastrointestinal Biotech Company Renexxion Ireland Announces $100M Investment Commitment
ROSCREA, Ireland, April 12, 2022 /PRNewswire/ -- Renexxion Ireland Ltd., a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need in gastrointestinal ("GI") disorders, announced today that it has entered into a share subscription agreement with...
2022-04-12 20:00
2253
Esaote S.p.A. turns 40 and is confirmed as a leading player in the world market for diagnostic imaging with ultrasound systems, magnetic resonance imaging and information technology for healthcare
GENOA, Italy, April 12, 2022 /PRNewswire/ -- Esaote S.p.A., a leading
biomedical company in the diagnostic imaging sector - in the fields of
ultrasound, magnetic resonance and Information Technology for health -
celebrates forty years of activity.
2022-04-12 19:00
2444
New Clinical Advisory Board to support PromarkerD global rollout
* Proteomics International establishes world class Clinical Advisory Board
promarkerd.com/clinical-advisory-board
2022-04-12 16:04
1871
CMG901 for the treatment of gastric cancer and gastroesophageal junction adenocarcinoma was granted the Orphan-drug Designation by the Food and Drug Administration of the United States
CHENGDU, China, April 12, 2022 /PRNewswire/ -- Keymed Biosciences (2162.HK) announced that its new drug candidate CMG901 (the "Claudin 18.2 antibody drug conjugates") for the treatment of gastric cancer and gastroesophageal junction adenocarcinoma has been granted the Orphan-drug Designation by t...
2022-04-12 15:45
1440
/DISREGARD RELEASE: HanAll Biopharma and Daewoong Pharmaceutical/
We are advised by HanAll Biopharma and Daewoong Pharmaceutical that journalists and other readers should disregard the news release, "Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative", issued11-Apr-2022 over PR Newswire. ...
2022-04-12 15:34
2803
Abbott Senior Medical Director joins Nutromics as inaugural Chief Medical Officer
MELBOURNE, Australia, April 12, 2022 /PRNewswire/ -- Australian and US MedTech start-up Nutromics (Nutromics or the Company), a global leader in DNA-based biosensors, today announced that DrAgim Beshiri, most recently Senior Medical Director at Abbott Laboratories, has joined the organisation as ...
2022-04-12 09:28
1764
VenusP-Valve(TM) obtains CE marking under MDR and debuts in Europe as China's first valve product
HANGZHOU, China, April 12, 2022 /PRNewswire/ -- On April 8th, 2022, VenusP-Valve TM, Venus Medtech's in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, received CE marking under the Medical Devices Regulation (MDR) to be marketed inEurope. Designed to treat patie...
2022-04-12 09:20
1494
Strong Growth in Digital Health Powers MediHeroes, A Cross Border B2B Medical Platform
SINGAPORE, April 12, 2022 /PRNewswire/ -- MediHeroes will launch a "Verify Before Buy" platform created especially for suppliers, buyers and service providers in the MedTech industry onApril 15, 2022. A transformative industry platform, MediHeroes helps buyers and sellers save months to years ...
2022-04-12 09:00
1782
ProstACT Update: TARGET Study Ethics Approval
MELBOURNE, Australia, April 12, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its ProstACT TARGET Phase II clinical trial of the Company's prostate cancer antibody therapy candidate TLX591 (177Lu-DOTA-rosopatamab), in patients experiencing a fir...
2022-04-12 07:47
2013
The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for the First-Line Treatment of Small Cell Lung Cancer Accepted by NMPA
SHANGHAI, April 11, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of HANSIZHUANG (serplulimab), a novel anti-PD-1 monoclonal antibody (mAb) independently developed by the company, in combination with chemotherapy for the first-line tr...
2022-04-11 22:07
3553
PharmAbcine Presents Updated Preclinical Data of Its Anti-VISTA Antibody Candidate at AACR 2022
DAEJEON, South Korea, April 11, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), aclinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company presented an updated preclinical data PMC-309, the Company's anti-VISTA ...
2022-04-11 20:00
1755
Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program
Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas MOUNTAIN VIEW, Calif., April 11, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation com...
2022-04-11 19:00
2762
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 278 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 275 media titles]
2026-10-09 13:21DayOne Upsizes Malaysia Financing to US$7.2 Billion; Total Billings Surpass 1GW and Bookings Reach 2.3GW
[Picked up by 269 media titles]
2026-10-14 18:01Ampotech and Buskowitz Energy Collaborate to Deliver Integrated Energy Solutions Combining Energy Efficiency, Solar and Battery Storage
[Picked up by 263 media titles]
2026-10-14 09:30
Most Read
Nuix Neo Generative AI Framework
2026-10-08 08:02
14818
LEIFRAS Co., Ltd. Reports First Half of Fiscal Year 2026 Financial Results
2026-10-08 09:50
12807
XPENG G9L Completes First Production Trial in Europe
2026-10-08 07:33
12377
